Everything about regulatory audits in pharma
Course of action validation really should affirm that the impurity profile for each API is within the limitations specified. The impurity profile really should be corresponding to, or better than, historical details and, where by relevant, the profile identified through method development or for batches useful for pivotal medical and toxicological